BusinessaTyr Pharma to Host Conference Call and Webcast of First Quarter 2018 Financial Results on May 14, 2018By Nasdaq OMXMay 8, 2018, 12:01 PM UTC
BusinessaTyr Pharma Provides Mechanistic Update on Resokine Pathway at American Academy of Immunology Annual MeetingBy Nasdaq OMXMay 2, 2018, 12:01 PM UTC
BusinessaTyr Pharma Announces Fourth Quarter and Year-End 2017 Operating Results and Provides Corporate UpdateBy Nasdaq OMXMar 19, 2018, 8:05 PM UTC
BusinessaTyr Pharma to Host Conference Call and Webcast of Full Year 2017 Financial Results on March 19, 2018By Nasdaq OMXMar 7, 2018, 1:01 PM UTC
BusinessaTyr Pharma to Present at Two Upcoming Investor Conferences in MarchBy Nasdaq OMXMar 1, 2018, 1:00 PM UTC
BusinessaTyr Pharma Doses First Subjects in Phase 1 Trial of iMod.Fc (ATYR1923)By Nasdaq OMXNov 27, 2017, 1:01 PM UTC
